FY2021 · ended Jul 31, 2020 · Revenue $0 · Filed Oct 29, 2021
Odyssey Health, Inc. (ODYY) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus.
Revenue
$0
Net income
$-5.73M
-228.8% vs prior year
Operating cash flow
$-1.05M
-201.2% vs prior year
Free cash flow
$-116,598
-81.7% vs prior year
EPS
$-0.05
-150.0% vs prior year
Dividend per share
None
Shares outstanding
110.22M
+10.4% vs prior year
Net cash
$556,584
FY 2021
Operating margin
—
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- ODYY (OTC)
- Fiscal year ends
- July 31
- Incorporated in
- NV
- Headquarters
- Las Vegas, NV
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1626644
- Former names
- Odyssey Group International, Inc. (until Feb 18, 2022)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2026 Jul 31, 2026 |
FY 2025 Jul 31, 2025 |
FY 2024 Jul 31, 2024 |
FY 2023 Jul 31, 2023 |
FY 2022 Jul 31, 2022 |
|---|---|---|---|---|---|
| Operating income | -$912,994 | -$1.0M | -$2.1M | -$5.3M | -$8.1M |
| Net income | -$5.7M | -$1.7M | -$842,316 | -$5.9M | -$8.4M |
| Diluted EPS | -$0.05 | -$0.02 | -$0.01 | -$0.07 | -$0.09 |
| Operating cash flow | -$1.0M | -$347,392 | -$1.2M | — | -$1.5M |
| Total assets | $147,859 | $49,723 | $586,146 | $455,793 | $569,677 |
| Stockholders' equity | -$12.1M | -$7.0M | -$5.3M | -$6.2M | -$4.6M |
| Cash and investments | $122,361 | $19,084 | $2,379 | $36,865 | $72,534 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-K | Annual report | Oct 28, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Oct 5, 2026 | Sep 29, 2026 |
| 10-Q | Quarterly report | Jun 12, 2026 | Apr 30, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
May 26, 2026 | Sep 18, 2025 |
| 8-K |
Current report
Material agreement
|
May 11, 2026 | May 6, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 24, 2026 | Apr 21, 2026 |
All 275 Odyssey Health, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.